| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Hyejung Mok | Q88436931 |
| Yu-Kyoung Oh | Q89902367 | ||
| P2093 | author name string | Tae Gwan Park | |
| Ji Hoon Jeong | |||
| P433 | issue | 1 | |
| P304 | page(s) | 5-14 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Bioconjugate Chemistry | Q2343023 |
| P1476 | title | siRNA conjugate delivery systems | |
| P478 | volume | 20 |
| Q50195234 | "Clicking" gene therapeutics: A successful union of chemistry and biomedicine for new solutions. |
| Q50522491 | 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo. |
| Q38311422 | A universal protein tag for delivery of SiRNA-aptamer chimeras |
| Q36589333 | Advanced materials and processing for drug delivery: the past and the future |
| Q39250878 | Advances in siRNA delivery in cancer therapy |
| Q36341433 | Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems |
| Q42274452 | Amphiphilic polyethylenimine polymers mediate efficient delivery of DNA and siRNA in mammalian cells |
| Q35823611 | Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group |
| Q33875414 | Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing |
| Q37976494 | Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics |
| Q48282746 | Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy. |
| Q38121824 | Chemistry and formulations for siRNA therapeutics |
| Q60467863 | Chitosan and its derivatives as nanocarriers for siRNA delivery |
| Q39673421 | Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. |
| Q36619965 | Circularized synthetic oligodeoxynucleotides serve as promoterless RNA polymerase III templates for small RNA generation in human cells |
| Q37765187 | Clinical developments in nanotechnology for cancer therapy |
| Q33660805 | Combinatorial approach to determine functional group effects on lipidoid-mediated siRNA delivery |
| Q58001525 | Conjugation of DNA with Biomolecules and Nanoparticles |
| Q39560988 | Conjugation of siRNA with comb-type PEG enhances serum stability and gene silencing efficiency |
| Q39651726 | Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery |
| Q92755701 | Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery |
| Q30574647 | Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics |
| Q37922198 | Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review |
| Q35046391 | Degradable polyelectrolyte multilayers that promote the release of siRNA |
| Q38226666 | Delivering the promise of small ncRNA therapeutics |
| Q38154803 | Delivery materials for siRNA therapeutics |
| Q37936378 | Delivery of RNAi mediators |
| Q38160246 | Delivery of RNAi therapeutics: work in progress |
| Q34293708 | Delivery of siRNA therapeutics: barriers and carriers |
| Q41467900 | Dendronized gold nanoparticles for siRNA delivery. |
| Q36170747 | Designed guanidinium-rich amphipathic oligocarbonate molecular transporters complex, deliver and release siRNA in cells |
| Q39631310 | Di‐ and Triblock siRNA‐PEG Copolymers: PEG Density Effect of Polyelectrolyte Complexes on Cellular Uptake and Gene Silencing Efficiency |
| Q37256184 | Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain |
| Q34097275 | Dynamics of nucleic acid/cationic polymer complexation and disassembly under biologically simulated conditions using in situ atomic force microscopy |
| Q33824686 | Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery |
| Q42389499 | Effect of nanoparticle conjugation on gene silencing by RNA interference |
| Q42952676 | Effective Stabilization and Delivery of siRNA: Reversible siRNA−Phospholipid Conjugate in Nanosized Mixed Polymeric Micelles |
| Q34149828 | Efficient and targeted delivery of siRNA in vivo |
| Q92341122 | Efficient nanocarriers of siRNA therapeutics for cancer treatment |
| Q37849727 | Engineering Nanocarriers for siRNA Delivery. |
| Q39277700 | Enhancement of gene silencing effect and membrane permeability by Peptide-conjugated 27-nucleotide small interfering RNA. |
| Q48207934 | Environmentally Triggerable Retinoic Acid-Inducible Gene I Agonists Using Synthetic Polymer Overhangs. |
| Q37316951 | FLEth RNA intercalating probe is a convenient reporter for small interfering RNAs |
| Q42248497 | FRET-labeled siRNA probes for tracking assembly and disassembly of siRNA nanocomplexes |
| Q37194010 | Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules |
| Q39429999 | Gold nanorod-sphingosine kinase siRNA nanocomplexes: a novel therapeutic tool for potent radiosensitization of head and neck cancer |
| Q33440795 | Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery |
| Q39505101 | Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA. |
| Q39779323 | Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing |
| Q50234594 | In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model. |
| Q33765102 | In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease |
| Q36335944 | In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery |
| Q90184104 | Innovative approaches for cancer treatment: current perspectives and new challenges |
| Q57363419 | Intelligent nucleic acid delivery systems based on stimuli-responsive polymers |
| Q39844898 | Kinetic analysis of RNA interference for lamin A/C in HeLa cells |
| Q99579064 | Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells |
| Q35598648 | Light-mediated activation of siRNA Release in diblock copolymer assemblies for controlled gene silencing |
| Q34155795 | Lipid and polymeric carrier-mediated nucleic acid delivery |
| Q84969771 | Medicinal Chemistry of siRNA Delivery |
| Q35215082 | Monitoring penetratin interactions with lipid membranes and cell internalization using a new hydration-sensitive fluorescent probe. |
| Q50568503 | Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. |
| Q37891091 | Nanocarriers: a tool to overcome biological barriers in siRNA delivery. |
| Q39066848 | Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy |
| Q42083011 | Nanoplatforms for magnetic resonance imaging of cancer. |
| Q41514193 | Natural and artificial small RNAs: a promising avenue of nucleic acid therapeutics for cancer |
| Q39660840 | Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice |
| Q42214886 | Nonviral gene delivery system |
| Q38176441 | Novel RNA interference-based therapies for sepsis |
| Q38050777 | Nucleic acid-based nanoengineering: novel structures for biomedical applications |
| Q34961061 | Optimized method for the synthesis and purification of adenosine--folic acid conjugates for use as transcription initiators in the preparation of modified RNA. |
| Q43216544 | Para amino benzoic acid-derived self-assembled biocompatible nanoparticles for efficient delivery of siRNA. |
| Q38747732 | Peptide-Based and Polypeptide-Based Gene Delivery Systems |
| Q37395691 | Peptide-functionalized nanogels for targeted siRNA delivery. |
| Q42283679 | Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery |
| Q41790614 | Precisely tunable engineering of sub-30 nm monodisperse oligonucleotide nanoparticles |
| Q36449335 | RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications |
| Q37597161 | RNA interference technologies and therapeutics: from basic research to products |
| Q38648525 | Recent advances in siRNA delivery |
| Q38023545 | Recent progress in copolymer-mediated siRNA delivery. |
| Q42373829 | Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells |
| Q35975665 | Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing |
| Q39768994 | Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. |
| Q30734485 | Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary Fibrosis |
| Q37855596 | Self-assembled and nanostructured siRNA delivery systems |
| Q89639578 | Single Functionalized pRNA/Gold Nanoparticle for Ultrasensitive MicroRNA Detection Using Electrochemical Surface-Enhanced Raman Spectroscopy |
| Q37638814 | Site-specific antibody-polymer conjugates for siRNA delivery |
| Q37793079 | Smart siRNA Delivery Systems Based on Polymeric Nanoassemblies and Nanoparticles |
| Q42912325 | Solid-Supported Synthesis and Click Conjugation of 4′-C-Alkyne Functionalized Oligodeoxyribonucleotides |
| Q34239177 | Spherical nucleic acids as a divergent platform for synthesizing RNA-nanoparticle conjugates through enzymatic ligation |
| Q37619111 | Strategies for targeted nonviral delivery of siRNAs in vivo |
| Q48208830 | Synthesis and Evaluation of Parenchymal Retention and Efficacy of a Metabolically Stable O-Phosphocholine-N-docosahexaenoyl-l-serine siRNA Conjugate in Mouse Brain. |
| Q39602646 | Synthesis and in vitro inhibition properties of siRNA conjugates carrying glucose and galactose with different presentations |
| Q35831738 | Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy |
| Q39129886 | Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures. |
| Q34389283 | Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation |
| Q28087657 | Technologies for controlled, local delivery of siRNA |
| Q38885511 | Therapeutic Potentials of Noncoding RNAs: Targeted Delivery of ncRNAs in Cancer Cells |
| Q37330601 | Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system |
| Q38268541 | Therapeutic face of RNAi: in vivo challenges |
| Q39665792 | Thermally Triggered Cellular Uptake of Quantum Dots Immobilized with Poly(N-isopropylacrylamide) and Cell Penetrating Peptide |
| Q54289151 | Tissue specific delivery of estrone-conjugated siRNAs. |
| Q38314361 | Tracking the down-regulation of folate receptor-α in cancer cells through target specific delivery of quantum dots coupled with antisense oligonucleotide and targeted peptide |
| Q42148447 | Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity |
| Q42826162 | Virus-like particles with removable cyclodextrins enable glutathione-triggered drug release in cells |
| Q38978041 | siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing |
Search more.